| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.2B | $16.4B | $17.1B | $22.7B | $19.9B | $2.5B | $1.8B | $1.8B |
| Cost of Revenue | $10.6B | $11.0B | $11.1B | $15.0B | $14.0B | $6.3B | $5.3B | $5.8B |
| Gross Profit | $4.6B | $5.4B | $6.0B | $7.7B | $5.9B | $0.7B | $0.5B | $0.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.8B | $3.8B | $3.8B | $4.0B | $3.5B | $1.7B | $1.6B | $1.6B |
| Operating Income | $0.8B | $1.6B | $2.2B | $3.8B | $2.4B | $0.5B | $0.4B | $0.4B |
| Net Income | $0.4B | $1.1B | $1.5B | $2.7B | $1.7B | $0.1B | $0.0B | $0.1B |
| EPS (Basic) | $3.91 | $9.13 | $12.06 | $16.98 | $8.55 | $1.20 | $0.36 | $0.45 |
| EPS (Diluted) | $3.89 | $9.06 | $11.94 | $16.82 | $8.48 | $1.18 | $0.35 | $0.45 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.2B | $10.6B | $10.5B | $10.6B | $10.7B | $4.2B | $3.2B | $2.9B |
| Current Assets | $2.9B | $3.1B | $3.3B | $3.5B | $4.0B | $2.2B | $1.3B | $1.4B |
| Cash & Equivalents | $0.2B | $0.2B | $0.1B | $0.1B | $0.0B | $0.4B | $0.0B | $0.0B |
| Total Liabilities | $6.9B | $6.3B | $5.8B | $5.6B | $5.9B | $3.0B | $2.4B | $2.3B |
| Current Liabilities | $1.6B | $1.8B | $1.9B | $1.8B | $2.1B | $1.1B | $0.8B | $0.7B |
| Stockholders' Equity | $4.4B | $4.3B | $4.7B | $5.0B | $4.8B | $1.2B | $0.8B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.9B | $2.3B | $3.6B | $1.7B | $0.3B | $0.5B | $0.3B |
| Investing Cash Flow | $-1.5B | $-0.7B | $-0.7B | $-1.0B | $-1.3B | $-0.1B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.4B | $0.4B | $0.5B | $0.3B | $0.2B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $0.3B | $-1.1B | $-1.7B | $-2.6B | $-0.8B | $0.3B | $-0.3B | $-0.2B |